337 related articles for article (PubMed ID: 19136997)
1. The role of fat topology in the risk of disease.
Matsuzawa Y
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin: a key player in obesity related disorders.
Matsuzawa Y
Curr Pharm Des; 2010 Jun; 16(17):1896-901. PubMed ID: 20370675
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome and adipocytokines.
Matsuzawa Y
FEBS Lett; 2006 May; 580(12):2917-21. PubMed ID: 16674947
[TBL] [Abstract][Full Text] [Related]
4. White adipose tissue and cardiovascular disease.
Matsuzawa Y
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
[TBL] [Abstract][Full Text] [Related]
5. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
Matsuzawa Y
Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
[TBL] [Abstract][Full Text] [Related]
6. Adipocytokines and metabolic syndrome.
Matsuzawa Y
Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and metabolic syndrome.
Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
[TBL] [Abstract][Full Text] [Related]
8. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
10. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.
Matsuzawa Y; Funahashi T; Nakamura T
J Atheroscler Thromb; 2011; 18(8):629-39. PubMed ID: 21737960
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome and adipocytokines.
Matsuzawa Y
Expert Rev Clin Immunol; 2007 Jan; 3(1):39-46. PubMed ID: 20476950
[TBL] [Abstract][Full Text] [Related]
12. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances.
Matsuzawa Y; Funahashi T; Nakamura T
Ann N Y Acad Sci; 1999 Nov; 892():146-54. PubMed ID: 10842660
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.
Kranendonk ME; van Herwaarden JA; Stupkova T; de Jager W; Vink A; Moll FL; Kalkhoven E; Visseren FL
Atherosclerosis; 2015 Apr; 239(2):419-27. PubMed ID: 25682042
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a concept of visceral fat syndrome and discovery of adiponectin.
Matsuzawa Y
Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(2):131-41. PubMed ID: 20154470
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
Hajer GR; van Haeften TW; Visseren FL
Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk of adipokines: a review.
Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
[TBL] [Abstract][Full Text] [Related]
18. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
[TBL] [Abstract][Full Text] [Related]
19. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: clinical concept and molecular basis.
Funahashi T; Matsuzawa Y
Ann Med; 2007; 39(7):482-94. PubMed ID: 17852038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
